A novel use of intravitreal injection callipers


Recently, anti-VEGF therapies, using bevacizumab or ranibizumab, show favourable results in CNV to various underlying diseases. However, there has been no report treated with ranibizumab in angioid streaks. In our case, though the left eye treated with PDT showed disappointing results, the VA of the right eye treated with ranibizumab has been stable for 1 year after treatments. We think that the treatment of CNV in angioid streaks with ranibizumab is also promising and encouraging therapy, which merits further investigations.

DOI: 10.1038/eye.2008.327

1 Figure or Table

Cite this paper

@article{Khan2009ANU, title={A novel use of intravitreal injection callipers}, author={Kamron Nasser Khan and Colin J Vize}, journal={Eye}, year={2009}, volume={23}, pages={1751-1751} }